Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway
2025

Botulinum Toxin Type A and Hypertrophic Scars

Sample size: 8 publication 10 minutes Evidence: high

Author Information

Author(s): Fan Yan, Guo Xuesong, Tian Yu, Li Jie, Xi Hongwei

Primary Institution: Children’s Hospital of Shanxi

Hypothesis

Does Botulinum toxin type A inhibit hypertrophic scar formation through the JAK2/STAT3 pathway?

Conclusion

Botulinum toxin type A inhibits the JAK2/STAT3 pathway, reducing the proliferation, migration, and fibrosis of hypertrophic scar fibroblasts and promoting wound healing.

Supporting Evidence

  • BTA treatment reduced cell viability and proliferation in hypertrophic scar fibroblasts.
  • AG490 treatment decreased the levels of fibrosis markers in HSFs.
  • BTA promoted wound healing in a mouse model by reducing collagen deposition.

Takeaway

Botulinum toxin can help prevent thick scars by stopping certain cells from growing too much and helps wounds heal better.

Methodology

The study involved isolating and culturing fibroblasts from hypertrophic scar patients, treating them with Botulinum toxin and analyzing the effects on the JAK2/STAT3 pathway and fibrosis markers.

Limitations

The study does not explore the interaction of Botulinum toxin with other signaling pathways involved in scar formation.

Participant Demographics

Patients with hypertrophic scars, aged between 3 months to 1 year post-injury.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.17305/bb.2024.10906

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication